Schubert & Co’s Prothena Corp PRTA Stock Holding History

Schubert & Co’s Portfolio PRTA Stock Details PRTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-14	Closed	-$679	–	1145
2023 Q1	$679	Buy	14 +1	+8%	+$53	﹤0.01%	1332
2022 Q4	$783	Buy	13 +3	+30%	+$176	﹤0.01%	1263
2022 Q3	$1K	Buy	10 +4	+67%	+$126	﹤0.01%	1217
2022 Q2	$0	Buy	6 +3	+100%	+$88	﹤0.01%	1560
2022 Q1	$0	Buy	+3	New	+$108	﹤0.01%	1286

Other funds holding PRTA

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Schubert & Co's PRTA Position: Q2 2023 in Review

Schubert & Co sold out of Prothena Corp (PRTA) in Q2 2023, closing a stake of 14 shares — an estimated $679 sold.

Schubert & Co first reported a position in PRTA in Q1 2022 and held it in 5 quarters. The position peaked at $1K in Q3 2022. 196 funds tracked by Wall St. Rank hold PRTA as of Q2 2023.

Schubert & Co reported no remaining Prothena Corp position as of Q2 2023 after selling out during the quarter.
Schubert & Co sold 14 Prothena Corp shares in Q2 2023, an estimated $679.
Schubert & Co first reported a position in Prothena Corp in Q1 2022 and held it in 5 quarters.
Schubert & Co's Prothena Corp position peaked at $1K in Q3 2022.
196 funds tracked by Wall St. Rank held Prothena Corp as of Q2 2023.

Based on Schubert & Co's 13F filing for Q2 2023, filed 4 Aug 2023.